Second, future RCTs should incorporate mechanistic endpoints to elucidate pathways through which probiotics may influence acne, including gut and skin microbiome sequencing, short-chain fatty acid profiling, assessments of epithelial barrier integrity, and biomarkers related to IGF-1 and mTORC1 signaling. This evidence concerns the gene IGF1 and acne.